{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:30:59Z","timestamp":1778549459452,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12931-018-0939-0","type":"journal-article","created":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T09:11:55Z","timestamp":1543828315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Soluble epoxide hydrolase derived lipid mediators are elevated in bronchoalveolar lavage fluid from patients with sarcoidosis: a cross-sectional study"],"prefix":"10.1186","volume":"19","author":[{"given":"Marcus O. D.","family":"Sj\u00f6din","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Checa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven-Erik","family":"Dahl\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5sa M.","family":"Wheelock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Grunewald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8113-0653","authenticated-orcid":false,"given":"Craig E.","family":"Wheelock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,3]]},"reference":[{"key":"939_CR1","doi-asserted-by":"crossref","unstructured":"Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, Eklund A, Kitaichi M, Lynch J, Rizzato G, et al: Statement on sarcoidosis. Am J Respir Crit Care Med 1999; 160:736\u2013755.","DOI":"10.1164\/ajrccm.160.2.ats4-99"},{"key":"939_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ccm.2008.03.002","volume":"29","author":"V Mihailovic-Vucinic","year":"2008","unstructured":"Mihailovic-Vucinic V, Jovanovic D. Pulmonary sarcoidosis. Clin Chest Med. 2008;29:459\u201373.","journal-title":"Clin Chest Med"},{"key":"939_CR3","doi-asserted-by":"crossref","unstructured":"Arkema EV, Grunewald J, Kullberg S, Eklund A, Askling J. Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden. Eur Respir J. 2016.","DOI":"10.1183\/13993003.00477-2016"},{"key":"939_CR4","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1056\/NEJM199704243361706","volume":"336","author":"LS Newman","year":"1997","unstructured":"Newman LS, Rose CS, Maier LA. Medical progress - Sarcoidosis. N Engl J Med. 1997;336:1224\u201334.","journal-title":"N Engl J Med"},{"key":"939_CR5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0954-6111(98)90086-5","volume":"92","author":"J Muller-Quernheim","year":"1998","unstructured":"Muller-Quernheim J. Sarcoidosis: clinical manifestations, staging and therapy (part II). Respir Med. 1998;92:140\u20139.","journal-title":"Respir Med"},{"key":"939_CR6","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"D Valeyre","year":"2014","unstructured":"Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet P-Y, M\u00fcller-Quernheim J. Sarcoidosis. Lancet. 2014;383:1155\u201367.","journal-title":"Lancet"},{"key":"939_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1164\/rccm.201006-0865CI","volume":"183","author":"RP Baughman","year":"2011","unstructured":"Baughman RP, Culver DA, Judson MA. A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med. 2011;183:573\u201381.","journal-title":"Am J Respir Crit Care Med"},{"key":"939_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1165\/rcmb.2002-0164PS","volume":"27","author":"DR Moller","year":"2002","unstructured":"Moller DR, Chen ES. Genetic basis of remitting sarcoidosis - triumph of the trimolecular complex? Am J Respir Cell Mol Biol. 2002;27:391\u20135.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"939_CR9","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00109-012-0954-4","volume":"90","author":"S Uderhardt","year":"2012","unstructured":"Uderhardt S, Kronke G. 12\/15-lipoxygenase during the regulation of inflammation, immunity, and self-tolerance. Journal of Molecular Medicine-Jmm. 2012;90:1247\u201356.","journal-title":"Journal of Molecular Medicine-Jmm"},{"key":"939_CR10","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/MCP.0b013e3283043de7","volume":"14","author":"J Grunewald","year":"2008","unstructured":"Grunewald J. Genetics of sarcoidosis. Curr Opin Pulm Med. 2008;14:434\u20139.","journal-title":"Curr Opin Pulm Med"},{"key":"939_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1055\/s-0030-1262206","volume":"31","author":"J Grunewald","year":"2010","unstructured":"Grunewald J. Review: role of genetics in susceptibility and outcome of sarcoidosis. Seminars in Respiratory and Critical Care Medicine. 2010;31:380\u20139.","journal-title":"Seminars in Respiratory and Critical Care Medicine"},{"key":"939_CR12","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1164\/ajrccm.156.5.9704069","volume":"156","author":"M Berlin","year":"1997","unstructured":"Berlin M, FogdellHahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med. 1997;156:1601\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"939_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.rmed.2014.11.009","volume":"109","author":"ADM Vorselaars","year":"2015","unstructured":"Vorselaars ADM, van Moorsel CHM, Zanen P, Ruven HJT, Claessen AME, van Velzen-Blad H, Grutters JC. ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy. Respir Med. 2015;109:279\u201385.","journal-title":"Respir Med"},{"key":"939_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s10875-012-9754-4","volume":"33","author":"E Bargagli","year":"2013","unstructured":"Bargagli E, Bennett D, Maggiorelli C, Di Sipio P, Margollicci M, Bianchi N, Rottoli P. Human Chitotriosidase: a sensitive biomarker of sarcoidosis. J Clin Immunol. 2013;33:264\u201370.","journal-title":"J Clin Immunol"},{"issue":"1","key":"939_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1378\/chest.124.1.186","volume":"124","author":"Jan C. Grutters","year":"2003","unstructured":"Grutters JC, Fellrath JM, Mulder L, Janssen R, van den Bosch JMM, van Velzen-Blad H: Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis - a clinical evaluation. Chest 2003; 124:186\u2013195.","journal-title":"Chest"},{"key":"939_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ccm.2008.03.004","volume":"29","author":"E Bargagli","year":"2008","unstructured":"Bargagli E, Mazzi A, Rottoli P. Markers of inflammation in sarcoidosis: blood, urine, BAL, sputum, and exhaled gas. Clin Chest Med. 2008;29:445.","journal-title":"Clin Chest Med"},{"key":"939_CR17","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/mnfr.201200840","volume":"57","author":"D Balgoma","year":"2013","unstructured":"Balgoma D, Checa A, Sar DG, Snowden S, Wheelock CE. Quantitative metabolic profiling of lipid mediators. Mol Nutr Food Res. 2013;57:1359\u201377.","journal-title":"Mol Nutr Food Res"},{"key":"939_CR18","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1016\/j.jaci.2009.10.047","volume":"125","author":"RF Lemanske","year":"2010","unstructured":"Lemanske RF, Busse WW. Asthma: clinical expression and molecular mechanisms. J Allergy Clin Immunol. 2010;125:S95\u2013S102.","journal-title":"J Allergy Clin Immunol"},{"key":"939_CR19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ejphar.2008.02.094","volume":"585","author":"AJ Nauta","year":"2008","unstructured":"Nauta AJ, Engels F, Knippels LM, Garssen J, Nijkamp FP, Redegeld FA. Mechanisms of allergy and asthma. Eur J Pharmacol. 2008;585:354\u201360.","journal-title":"Eur J Pharmacol"},{"key":"939_CR20","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1183\/09031936.00018908","volume":"31","author":"KF Chung","year":"2008","unstructured":"Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J. 2008;31:1334\u201356.","journal-title":"Eur Respir J"},{"key":"939_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.freeradbiomed.2012.05.001","volume":"53","author":"J Yang","year":"2012","unstructured":"Yang J, Eiserich JP, Cross CE, Morrissey BM, Hammock BD. Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients. Free Radic Biol Med. 2012;53:160\u201371.","journal-title":"Free Radic Biol Med"},{"key":"939_CR22","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1183\/13993003.01080-2015","volume":"47","author":"D Balgoma","year":"2016","unstructured":"Balgoma D, Yang M, Sjodin M, Snowden S, Karimi R, Levanen B, Merikallio H, Kaarteenaho R, Palmberg L, Larsson K, et al. Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD. Eur Respir J. 2016;47:1645\u201356.","journal-title":"Eur Respir J"},{"key":"939_CR23","doi-asserted-by":"publisher","first-page":"e43644","DOI":"10.1371\/journal.pone.0043644","volume":"7","author":"HH Olsen","year":"2012","unstructured":"Olsen HH, Grunewald J, Tornling G, Skold CM, Eklund A. Bronchoalveolar lavage results are independent of season, age, gender and collection site. PLoS One. 2012;7:e43644.","journal-title":"PLoS One"},{"key":"939_CR24","doi-asserted-by":"crossref","unstructured":"Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, Eklund A, Kitaichi M, Lynch J, Rizzato G, et al: ATS\/ERS\/WASOG statement on sarcoidosis. Sarcoidosis Vasculitis and Diffuse Lung Diseases 1999; 16:149\u2013173.","DOI":"10.1034\/j.1399-3003.1999.14d02.x"},{"key":"939_CR25","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1177\/1352458514561908","volume":"21","author":"A Checa","year":"2015","unstructured":"Checa A, Khademi M, Sar DG, Haeggstrom JZ, Lundberg JO, Piehl F, Olsson T, Wheelock CE. Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis. Mult Scler. 2015;21:1271\u20139.","journal-title":"Mult Scler"},{"key":"939_CR26","doi-asserted-by":"publisher","first-page":"15740","DOI":"10.1038\/srep15740","volume":"5","author":"A Checa","year":"2015","unstructured":"Checa A, Holm T, Sjodin MO, Reinke SN, Alm J, Scheynius A, Wheelock CE. Lipid mediator profile in vernix caseosa reflects skin barrier development. Sci Rep. 2015;5:15740.","journal-title":"Sci Rep"},{"key":"939_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/1467-9868.00346","volume":"64","author":"JD Storey","year":"2002","unstructured":"Storey JD. A direct approach to false discovery rates. Journal of the Royal Statistical Society Series B-Statistical Methodology. 2002;64:479\u201398.","journal-title":"Journal of the Royal Statistical Society Series B-Statistical Methodology"},{"key":"939_CR28","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1194\/jlr.R800038-JLR200","volume":"50","author":"AA Spector","year":"2009","unstructured":"Spector AA. Arachidonic acid cytochrome P450 epoxygenase pathway. J Lipid Res. 2009;50:S52\u20136.","journal-title":"J Lipid Res"},{"key":"939_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1152\/physrev.00021.2011","volume":"92","author":"JD Imig","year":"2012","unstructured":"Imig JD. Epoxides and soluble epoxide hydrolase in cardiovascular physiology. Physiol Rev. 2012;92:101\u201330.","journal-title":"Physiol Rev"},{"key":"939_CR30","doi-asserted-by":"crossref","unstructured":"Morisseau C, Hammock BD: Impact of soluble epoxide hydrolase and Epoxyeicosanoids on human health. In Annual Review of Pharmacology and Toxicology, Vol 53, 2013. Edited by Insel PA: 37\u201358 Annu Rev Pharmacol Toxicol.","DOI":"10.1146\/annurev-pharmtox-011112-140244"},{"key":"939_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/BF02737598","volume":"17","author":"DJ Conrad","year":"1999","unstructured":"Conrad DJ. The arachidonate 12\/15 lipoxygenases - a review of tissue expression and biologic function. Clin Rev Allergy Immunol. 1999;17:71\u201389.","journal-title":"Clin Rev Allergy Immunol"},{"key":"939_CR32","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1073\/pnas.0409591102","volume":"102","author":"KR Smith","year":"2005","unstructured":"Smith KR, Pinkerton KE, Watanabe T, Pedersen TL, Ma SJ, Hammock BD. Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor. Proc Natl Acad Sci U S A. 2005;102:2186\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"939_CR33","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1164\/rccm.201403-0544OC","volume":"190","author":"E Ono","year":"2014","unstructured":"Ono E, Dutile S, Kazani S, Wechsler ME, Yang J, Hammock BD, Douda DN, Tabet Y, Khaddaj-Mallat R, Sirois M, et al. Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma. Am J Respir Crit Care Med. 2014;190:886\u201397.","journal-title":"Am J Respir Crit Care Med"},{"key":"939_CR34","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1034\/j.1399-3003.1999.14c14.x","volume":"14","author":"A Gunther","year":"1999","unstructured":"Gunther A, Schmidt R, Nix F, Yabut-Perez M, Guth C, Rosseau S, Siebert C, Grimminger F, Morr H, Velcovsky HG, Seeger W. Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis. Eur Respir J. 1999;14:565\u201373.","journal-title":"Eur Respir J"},{"key":"939_CR35","doi-asserted-by":"publisher","first-page":"6387","DOI":"10.1021\/cr2002917","volume":"111","author":"AH Merrill","year":"2011","unstructured":"Merrill AH. Sphingolipid and glycosphingolipid metabolic pathways in the era of Sphingolipidomics. Chem Rev. 2011;111:6387\u2013422.","journal-title":"Chem Rev"},{"key":"939_CR36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1348-0421.2010.00198.x","volume":"54","author":"A Hartlova","year":"2010","unstructured":"Hartlova A, Cerveny L, Hubalek M, Krocova Z, Stulik J. Membrane rafts: a potential gateway for bacterial entry into host cells. Microbiol Immunol. 2010;54:237\u201345.","journal-title":"Microbiol Immunol"},{"key":"939_CR37","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0305799101","volume":"101","author":"RG Cutler","year":"2004","unstructured":"Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC, Mattson MP. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci U S A. 2004;101:2070\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"939_CR38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1378\/chest.13-0967","volume":"145","author":"J Tibboel","year":"2014","unstructured":"Tibboel J, Reiss I, de Jongste JC, Post M. Sphingolipids in lung growth and repair. Chest. 2014;145:120\u20138.","journal-title":"Chest"},{"issue":"7152","key":"939_CR39","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nature06014","volume":"448","author":"Miriam F. Moffatt","year":"2007","unstructured":"Moffatt MF, Kabesch M, Liang LM, Dixon AL, Strachan D, Heath S, Depner M, von Berg A, Bufe A, Rietschel E, et al: Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 2007; 448:470-U475.","journal-title":"Nature"},{"key":"939_CR40","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1124\/jpet.107.131565","volume":"324","author":"E Masini","year":"2008","unstructured":"Masini E, Giannini L, Nistri S, Cinci L, Mastroianni R, Xu W, Comhair SAA, Li D, Cuzzocrea S, Matuschak GM, Salvemini D. Ceramide: a key signaling molecule in a Guinea pig model of allergic asthmatic response and airway inflammation. J Pharmacol Exp Ther. 2008;324:548\u201357.","journal-title":"J Pharmacol Exp Ther"},{"key":"939_CR41","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nri2400","volume":"8","author":"J Rivera","year":"2008","unstructured":"Rivera J, Proia RL, Olivera A. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat Rev Immunol. 2008;8:753\u201363.","journal-title":"Nat Rev Immunol"},{"key":"939_CR42","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1096\/fj.00-0742fje","volume":"15","author":"AJ Ammit","year":"2001","unstructured":"Ammit AJ, Hastie AT, Edsall LC, Hoffman RK, Amrani Y, Krymskaya VP, Kane SA, Peters SP, Penn RB, Spiegel S, Panettieri RA. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J. 2001;15:1212\u20134.","journal-title":"FASEB J"},{"issue":"8","key":"939_CR43","doi-asserted-by":"publisher","first-page":"e23864","DOI":"10.1371\/journal.pone.0023864","volume":"6","author":"SL Lundstr\u00f6m","year":"2011","unstructured":"Lundstr\u00f6m SL, Lev\u00e4nen B, Nording M, Klepczynska-Nystr\u00f6m A, Sk\u00f6ld M, Haeggstr\u00f6m JZ, Grunewald J, Svartengren M, Hammock BD, Larsson BM, Eklund A, Wheelock \u00c5M, Wheelock CE. Asthmatics exhibit altered oxylipin profiles compared to healthy individuals after subway air exposure. PLoS One. 2011;6(8):e23864.","journal-title":"PLoS One"},{"issue":"1","key":"939_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/13547500802688194","volume":"14","author":"JE Wolak","year":"2009","unstructured":"Wolak JE, Esther CR Jr, O'Connell TM. Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients. Biomarkers. 2009;14(1):55\u201360.","journal-title":"Biomarkers"}],"container-title":["RESPIRATORY RESEARCH"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-018-0939-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-018-0939-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-018-0939-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T10:52:49Z","timestamp":1662547969000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-018-0939-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["939"],"URL":"https:\/\/doi.org\/10.1186\/s12931-018-0939-0","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"24 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Regional Ethical Review Board in Stockholm. Written informed consent was obtained from all subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"236"}}